BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 32603910)

  • 1. Controversy of physiological vs. pharmacological effects of BMP signaling: Constitutive activation of BMP type IA receptor-dependent signaling in osteoblast lineage enhances bone formation and resorption, not affecting net bone mass.
    Kamiya N; Atsawasuwan P; Joiner DM; Waldorff EI; Goldstein S; Yamauchi M; Mishina Y
    Bone; 2020 Sep; 138():115513. PubMed ID: 32603910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased BMP-Smad signaling does not affect net bone mass in long bones.
    Omi M; Koneru T; Lyu Y; Haraguchi A; Kamiya N; Mishina Y
    Front Physiol; 2023; 14():1145763. PubMed ID: 37064883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway.
    Kamiya N; Ye L; Kobayashi T; Mochida Y; Yamauchi M; Kronenberg HM; Feng JQ; Mishina Y
    Development; 2008 Nov; 135(22):3801-11. PubMed ID: 18927151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of BMP signaling through BMPR1A in osteoblasts leads to greater collagen cross-link maturation and material-level mechanical properties in mouse femoral trabecular compartments.
    Zhang Y; McNerny EG; Terajima M; Raghavan M; Romanowicz G; Zhang Z; Zhang H; Kamiya N; Tantillo M; Zhu P; Scott GJ; Ray MK; Lynch M; Ma PX; Morris MD; Yamauchi M; Kohn DH; Mishina Y
    Bone; 2016 Jul; 88():74-84. PubMed ID: 27113526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of BMP signaling in osteoblasts through type IA receptor (BMPRIA) increases bone mass.
    Kamiya N; Ye L; Kobayashi T; Lucas DJ; Mochida Y; Yamauchi M; Kronenberg HM; Feng JQ; Mishina Y
    J Bone Miner Res; 2008 Dec; 23(12):2007-17. PubMed ID: 18684091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted disruption of BMP signaling through type IA receptor (BMPR1A) in osteocyte suppresses SOST and RANKL, leading to dramatic increase in bone mass, bone mineral density and mechanical strength.
    Kamiya N; Shuxian L; Yamaguchi R; Phipps M; Aruwajoye O; Adapala NS; Yuan H; Kim HK; Feng JQ
    Bone; 2016 Oct; 91():53-63. PubMed ID: 27402532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone morphogenetic proteins.
    Chen D; Zhao M; Mundy GR
    Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of BMP signaling mediated by BMPR1A in osteoblasts leads to differential bone phenotypes in mice depending on anatomical location of the bones.
    Zhang H; Zhang Y; Terajima M; Romanowicz G; Liu Y; Omi M; Bigelow E; Joiner DM; Waldorff EI; Zhu P; Raghavan M; Lynch M; Kamiya N; Zhang R; Jepsen KJ; Goldstein S; Morris MD; Yamauchi M; Kohn DH; Mishina Y
    Bone; 2020 Aug; 137():115402. PubMed ID: 32360900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt inhibitors Dkk1 and Sost are downstream targets of BMP signaling through the type IA receptor (BMPRIA) in osteoblasts.
    Kamiya N; Kobayashi T; Mochida Y; Yu PB; Yamauchi M; Kronenberg HM; Mishina Y
    J Bone Miner Res; 2010 Feb; 25(2):200-10. PubMed ID: 19874086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role Of BMPs in the Regulation of Osteoclasts Resorption and Bone Remodeling: From Experimental Models to Clinical Applications.
    Bordukalo-Nikšić T; Kufner V; Vukičević S
    Front Immunol; 2022; 13():869422. PubMed ID: 35558080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual function of Bmpr1a signaling in restricting preosteoblast proliferation and stimulating osteoblast activity in mouse.
    Lim J; Shi Y; Karner CM; Lee SY; Lee WC; He G; Long F
    Development; 2016 Jan; 143(2):339-47. PubMed ID: 26657771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
    Okamoto M; Murai J; Yoshikawa H; Tsumaki N
    J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of BMP receptor type IB decreased bone mass in association with compromised osteoblastic differentiation of bone marrow mesenchymal progenitors.
    Shi C; Iura A; Terajima M; Liu F; Lyons K; Pan H; Zhang H; Yamauchi M; Mishina Y; Sun H
    Sci Rep; 2016 Apr; 6():24256. PubMed ID: 27048979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone morphogenetic protein type IA receptor signaling regulates postnatal osteoblast function and bone remodeling.
    Mishina Y; Starbuck MW; Gentile MA; Fukuda T; Kasparcova V; Seedor JG; Hanks MC; Amling M; Pinero GJ; Harada S; Behringer RR
    J Biol Chem; 2004 Jun; 279(26):27560-6. PubMed ID: 15090551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BmpR1A is a major type 1 BMP receptor for BMP-Smad signaling during skull development.
    Pan H; Zhang H; Abraham P; Komatsu Y; Lyons K; Kaartinen V; Mishina Y
    Dev Biol; 2017 Sep; 429(1):260-270. PubMed ID: 28641928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A soluble bone morphogenetic protein type IA receptor increases bone mass and bone strength.
    Baud'huin M; Solban N; Cornwall-Brady M; Sako D; Kawamoto Y; Liharska K; Lath D; Bouxsein ML; Underwood KW; Ucran J; Kumar R; Pobre E; Grinberg A; Seehra J; Canalis E; Pearsall RS; Croucher PI
    Proc Natl Acad Sci U S A; 2012 Jul; 109(30):12207-12. PubMed ID: 22761317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BMP Signaling Mediated by BMPR1A in Osteoclasts Negatively Regulates Osteoblast Mineralization Through Suppression of Cx43.
    Shi C; Zhang H; Louie K; Mishina Y; Sun H
    J Cell Biochem; 2017 Mar; 118(3):605-614. PubMed ID: 27649478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional characterization of bone morphogenetic proteins (BMPs)-mediated osteogenic signaling.
    Peng Y; Kang Q; Cheng H; Li X; Sun MH; Jiang W; Luu HH; Park JY; Haydon RC; He TC
    J Cell Biochem; 2003 Dec; 90(6):1149-65. PubMed ID: 14635189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained BMP signaling in osteoblasts stimulates bone formation by promoting angiogenesis and osteoblast differentiation.
    Zhang F; Qiu T; Wu X; Wan C; Shi W; Wang Y; Chen JG; Wan M; Clemens TL; Cao X
    J Bone Miner Res; 2009 Jul; 24(7):1224-33. PubMed ID: 19257813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Abl-dependent molecular circuitry involving Smad5 and phosphatidylinositol 3-kinase regulates bone morphogenetic protein-2-induced osteogenesis.
    Ghosh-Choudhury N; Mandal CC; Das F; Ganapathy S; Ahuja S; Ghosh Choudhury G
    J Biol Chem; 2013 Aug; 288(34):24503-17. PubMed ID: 23821550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.